Cargando…
Author's reply: Detailed Causality between Sodium-glucose Cotransporter 2 Inhibitor and Tubulointerstitial Nephritis
Autores principales: | Konta, Yusuke, Saito, Eiichiro, Sato, Koji, Furuta, Kyohei, Miyauchi, Kenichiro, Furukawa, Akiko, Sato, Hiroshi, Yamamoto, Tae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037006/ https://www.ncbi.nlm.nih.gov/pubmed/35871589 http://dx.doi.org/10.2169/internalmedicine.0341-22 |
Ejemplares similares
-
Tubulointerstitial Nephritis after Using a Sodium-glucose Cotransporter 2 Inhibitor
por: Konta, Yusuke, et al.
Publicado: (2022) -
Detailed Causality between Sodium-glucose Cotransporter 2 Inhibitor and Tubulointerstitial Nephritis
por: Morita, Hiroyasu, et al.
Publicado: (2022) -
Prognostic factors for acute ischemic stroke in patients undergoing hemodialysis
por: Sato, Koji, et al.
Publicado: (2021) -
Acute tubulointerstitial nephritis induced by checkpoint inhibitors versus classical acute tubulointerstitial nephritis: are they the same disease?
por: Draibe, Juliana B, et al.
Publicado: (2020) -
Immunohistochemical Characteristics of IgG4-Related Tubulointerstitial Nephritis: Detailed Analysis of 20 Japanese Cases
por: Kawano, Mitsuhiro, et al.
Publicado: (2012)